Robert Brooke Chief Executive Officer

Size: px
Start display at page:

Download "Robert Brooke Chief Executive Officer"

Transcription

1 Robert Brooke Chief Executive Officer

2 2 Safe Harbor Statement Our commentary and responses to your questions may contain forward-looking statements, including comments concerning product development programs, evaluation of potential opportunities, the level of corporate expenditures, the assessment of our technology by potential corporate partners, capital market conditions, timing of events, cash consumption and other subjects. Information concerning factors that could cause actual results to differ materially from those set forth in our regulatory filings from time to time.

3 3 We are an agricultural-biotechnology company building technologies and products that enable sustainable health Population growth and surging consumption is a ticking time bomb We need mass market solutions.

4 4 Sugar: Consumption at a Crossroads Credit Suisse Report, September 2013 Key conclusion: The most likely outcome over the next 5-10 years will be a significant reduction in sugar consumption and a marked increase in the role played by high-intensity natural sweeteners in foods and beverages.

5 5 Healthy product introductions at big companies are usually risky, but stevia is a no-brainer. Natural Sweeteners (sugar, honey,) Stevia natural zero calories Artificial Sweeteners (aspartame, saccharin, etc.) The holy grail of sweeteners is still in its infancy, but delivering on numerous fronts, and has strategic and technical competitive advantages that indicate it will be a winner long-term.

6 6 Stevia First s agri-bio technologies aim to define the future of stevia use and the stevia industry Stevia Fermentation: No leaf required through microbial fermentation Reliable, scaleable, and on-demand production of stevia that is tailored to consumer taste preferences Modern Ag and Hybrid-Fermentation: Leaf required in small quantities Expertise in domestic organic leaf production and extraction, providing capability for traditional or hybrid-fermentation production that eliminate necessity of overseas stevia plantations

7 7 Biosynthesis of Steviol Glycosides using the native stevia enzymes to produce Nature-Identical TM Stevia Source: Phytochemistry, Brandle, et.al., 2007

8 Intellectual Property related to Steviol Production using Fermentation Compositions and methods for producing steviol and steviol glycosides Patents and patent applications related to production of steviol and steviol glycosides through fermentation Steviol The Golden Gate Stevia 1.0 (Stevioside) Lower -cost inputs Stevia 2.0 (Reb A) Stevia 3.0 (Reb D?)

9 9 Pipeline Stevia and Next-Generation Stevia Sweeteners Stevia RA95 Stevia extract containing more than 95% Reb A. Process Discovery Process Development Process Scaleup Regulatory Approval Product Launch Stevia SGN95 ( Beyond Reb A ) Stevia extract containing more than 95% total Steviol Glycosides in Novel formulations. Process Discovery Process Development Process Scaleup Regulatory Approval Product Launch Fermentation-based production, modern organic leaf production, and hybrid production methods can be utilized based on consumer preferences

10 10 Strategic Product Development Through launching branded consumer products now, we re raising awareness for... our mission, and healthy product innovations that can influence the mass market. SF Natural TM - enjoy sweetness in its most natural form Sucrolette TM - we can quit sugar together in 5 weeks Dr. Mike Murray, ND -leading authority on natural approaches to health and wellness - Editor, The Encyclopedia of Natural Medicine Product Development Personalities Alexandra Jamieson -Nutrition counselor, health writer, and chef - Super Size Me documentary - Featured on Oprah, CNN, MSNBC

11 11 Stevia Production Platform On-demand production of stevia extracts to meet a wide variety of consumer demands and application needs Path to Value Creation Process Discovery Process Development Proof-ofconcept data Intellectual property Process Scaleup Proof-ofrelevance data Technology partnerships Key Drivers Commercial Validation Technology partnerships Commercial launch partnerships Commercial Launch Regulatory Approval Marketing partnerships Product Revenues

12 12 Leadership Avtar Dhillon, MD, Chairman & Cofounder Chairman, Inovio and Oncosec Venture capitalist Family medicine physician Anthony Maida, PhD, MBA, Director COO, Northwest Bio MBA, MA in Toxicology, PhD in Immunology, Family farm management experience Robert Brooke, CEO & Co-founder Ex-hedge fund analyst for over 50 direct healthcare investments Biotech entrepreneur, M.S. in Biomedical Engineering Jeremiah Mann, PhD, Sr. Agronomist, VP of Ops Ex-USDA and Natural Resource Conservation Service PhD in Horticulture and Agronomy, Univ of California Davis Richard McKilligan, JD, MBA, Controller Ex-Morgan, Lewis, & Bockius LLP, State Bars in CA and NY, CPA (inactive) JD from Cornell, MBA from Univ of Chicago, BS in Accounting from Univ of Illinois

13 Multidisciplinary Capabilities 13

14 14 Trading Highlights (Ticker: STVF) ~$30M market cap $0.49 share price Trading data as of Feb. 24, 2014

15 15 Financial Highlights a development-stage agricultural biotechnology firm Average volume (3m): 159,779 shares Recent financings (June & Dec. 2013): >$2.5M from stock and warrants Shareholder base: 8,351 shareholders Shares outstanding: 66,432,523 shares Auditors: Weinberg & Co. Transfer Agent: Island Stock Transfer Securities Counsel: Morrison & Foerster Stevia First Ticker: STVF Stock listing: OTCQB Stock price: $0.49 per share Market cap: ~$30 million Trading data as of Feb. 24, 2014

16 Industry Activity & Milestones INTRINSIC Entry into exclusive and worldwide license for steviol-related patents Stevia First s "Beyond Reb A" R&D Program disclosed publicly Pilot-Scale Testing of Domestic Stevia Extraction Production of Enhanced Steviol Glycosides Through Fermentation Stevia Tasting Event including Stevia using Fermentation Consumer Product Releases Aug 12 Mar 13 May 13 July 13 Dec 13 EXTRINSIC 16 Coca-Cola reformulates Sprite in UK with stevia; launches an anti-obesity ad campaign Purecircle (a leading supplier) announces Reb D is Stevia 3.0 Cargill invests in and partners with Evolva, a European company, for fermentationderived steviol glycosides Coca-Cola and Purecircle seek GRAS status and development of next-gen stevia Reb X Coca-Cola launches Coca-Cola Life using stevia and plant bottle with green labeling Data Release Process Scale-up for RA95 Data Release Process Discovery for SGN95, next-gen stevia Regulatory Update GRAS Approval Process for RA95 1H 14 Q3 14 Business Development (ongoing) Technology partnerships Commercial partnerships New licensing opportunities

17 Investment Highlights Fermentation-based stevia production is a breakthrough technology Intellectual property related to steviol glycoside production using fermentation Discussions for technology and commercial partnerships are ongoing Management and board contain leaders in biotechnology R&D with 20+ years of related public markets experience

Safe Harbor Statement

Safe Harbor Statement 2 Safe Harbor Statement This presentation and our commentary and responses to your questions may contain forward-looking statements, including comments concerning drug development programs, evaluation

More information

Forward-Looking Statements

Forward-Looking Statements Investor Presentation May 2012 Forward-Looking Statements Statements contained herein that are not historical facts are forward-looking statements within the meaning of the Securities Act of 1933, as amended.

More information

Corporate Presentation June OTCQB: VBIO

Corporate Presentation June  OTCQB: VBIO Corporate Presentation June 2018 @vitalitybio www.vitality.bio OTCQB: VBIO 2 Safe Harbor Statement This presentation and our commentary and responses to your questions may contain forward-looking statements,

More information

Food Specialties Patrick Niels President DSM Food Specialties ROYAL DSM HEALTH NUTRITION MATERIALS

Food Specialties Patrick Niels President DSM Food Specialties ROYAL DSM HEALTH NUTRITION MATERIALS Food Specialties Patrick Niels President DSM Food Specialties ROYAL DSM HEALTH NUTRITION MATERIALS Safe harbor statement This presentation may contain forward-looking statements with respect to DSM s future

More information

Corporate Presentation July

Corporate Presentation July Corporate Presentation July 2016 @vitalitybio www.vitality.bio 2 Cannabinoid Prodrugs Unlocking the power of cannabinoids to treat serious neurological and inflammatory disorders 3 Leadership entrepreneurial

More information

Investor Presentation June 2012 NASDAQ: CEMI

Investor Presentation June 2012 NASDAQ: CEMI Investor Presentation June 2012 NASDAQ: CEMI Forward-Looking Statements Statements contained herein that are not historical facts are forward-looking statements within the meaning of the Securities Act

More information

SPHERIX ANNOUNCES FIRST QUARTER 2010 FINANCIAL RESULTS

SPHERIX ANNOUNCES FIRST QUARTER 2010 FINANCIAL RESULTS SPHERIX Investor Relations Phone: (301) 897-2564 Email: info@spherix.com SPHERIX ANNOUNCES FIRST QUARTER 2010 FINANCIAL RESULTS BETHESDA, MD, May 21, 2010 - Spherix Incorporated (NASDAQ CM: SPEX), an innovator

More information

E N H A N C IN G HE A LTH THRO U GH CANNABIS S CIENCE

E N H A N C IN G HE A LTH THRO U GH CANNABIS S CIENCE I N V E S T O R P R E S E N TAT I O N Q 4 2 0 1 6 TM HEALTH THERAPEUTICS E N H A N C IN G HE A LTH THRO U GH CANNABIS S CIENCE T S X. V: E M H DISCLAIMER THE STATEMENTS MADE IN THIS PRESENTATION MAY INCLUDE

More information

Corporate Presentation June OTCQB: VBIO

Corporate Presentation June   OTCQB: VBIO Corporate Presentation June 2018 @vitalitybio www.vitality.bio OTCQB: VBIO 2 Safe Harbor Statement This presentation and our commentary and responses to your questions may contain forward-looking statements,

More information

NEXT-GENERATION STEVIA: A NEW WAVE OF EXTRACTS

NEXT-GENERATION STEVIA: A NEW WAVE OF EXTRACTS NEXT-GENERATION STEVIA: A NEW WAVE OF EXTRACTS April 2018 EXPERT INSIGHTS 02 Next-Generation Stevia: A New Wave of Extracts Natural sweeteners, including stevia, have been trending amid the clean label

More information

Innovation Spotlight:

Innovation Spotlight: Innovation Spotlight: Sugar reduction in dairy a natural fit for stevia?.. PureCircle April 2017 Agenda Reducing sugar without compromising taste Presenting consumer perception and positioning sugar reduction

More information

ADVANCES IN THE SCIENCE OF THE STEVIA LEAF: A PATH TO THE BEST TASTE AND SENSORY EXPERIENCE

ADVANCES IN THE SCIENCE OF THE STEVIA LEAF: A PATH TO THE BEST TASTE AND SENSORY EXPERIENCE ADVANCES IN THE SCIENCE OF THE STEVIA LEAF: A PATH TO THE BEST TASTE AND SENSORY EXPERIENCE 1 LETS PUT THINGS INTO PERSPECTIVE CONSUMERS ARE LOOKING FOR NATUTRAL ALTERNATIVES TO REPLACE SUGAR What? Seeking

More information

COMPANY PRESENTATION JULY Bob Bechard Executive Vice-President Corporate Development & Licensing

COMPANY PRESENTATION JULY Bob Bechard Executive Vice-President Corporate Development & Licensing COMPANY PRESENTATION JULY 2018 Bob Bechard Executive Vice-President Corporate Development & Licensing Forward Looking Statements Some statements in this release may contain forward-looking information.

More information

Technological Experiences and Advances in the Beverage Sector

Technological Experiences and Advances in the Beverage Sector Technological Experiences and Advances in the Beverage Sector Marge Leahy, PhD Director, Health and Wellness Institute of Medicine Food Forum Workshop Leveraging Food Technology for Obesity Prevention

More information

DSM Capital Markets Day 2018

DSM Capital Markets Day 2018 DSM Capital Markets Day 2018 Human Nutrition & Health Jeremy Xu President Human Nutrition & Health ROYAL DSM CAPITAL MARKETS DAY LONDON (UK) 20 JUNE 2018 Safe harbor statement This presentation may contain

More information

Media Kit. September 2017

Media Kit. September 2017 Media Kit September 2017 About Pear Pear Therapeutics is the leader in FDA-cleared Prescription Digital Therapeutics. The company s approach is to integrate clinically-validated software applications with

More information

The Stevia Plant. Zero in on Stevia Sweegen, Inc. All rights reserved.

The Stevia Plant. Zero in on Stevia Sweegen, Inc. All rights reserved. Zero in on Stevia Zero in on Stevia 2 In 2015, when the World Health Organization (WHO) issued guidelines with recommendations on daily sugar intake 1, they would start a change in how the world viewed

More information

FEMA Mission Statement and Critical Objectives

FEMA Mission Statement and Critical Objectives FEMA 2014-2015 Mission Statement and Critical Objectives Mission Statement: The Flavor and Extract Manufacturers Association furthers the business interests of its members through a sound scientific program

More information

CBI Product Factsheet:

CBI Product Factsheet: CBI Product Factsheet: Stevia in Europe CBI Market Intelligence Product Factsheet Cloves in Germany 1 Introduction Stevia is a new product in Europe. Food and beverage manufacturers are rapidly developing

More information

TSX Venture: RVV OTCQB: RVVTF

TSX Venture: RVV OTCQB: RVVTF TSX Venture: RVV OTCQB: RVVTF The image part with relationship ID rid3 was not found in the file. 2017 Annual General and Special Meeting of Shareholders December 19, 2017 Revive Therapeutics Ltd. Office:

More information

HILLENBRAND INDUSTRIES INC

HILLENBRAND INDUSTRIES INC HILLENBRAND INDUSTRIES INC FORM 8-K (Unscheduled Material Events) Filed 2/17/2004 For Period Ending 2/13/2004 Address 700 STATE ROUTE 46 E BATESVILLE, Indiana 47006-8835 Telephone 812-934-7000 CIK 0000047518

More information

Corporate Overview. February 2018 NASDAQ: CYTR

Corporate Overview. February 2018 NASDAQ: CYTR Corporate Overview February 2018 NASDAQ: CYTR CytRx Safe Harbor Statement THIS PRESENTATION CONTAINS FORWARD-LOOKING STATEMENTS THAT INVOLVE CERTAIN RISKS AND UNCERTAINTIES. ACTUAL RESULTS COULD DIFFER

More information

A vertically integrated global leader in the manufacturing of all natural stevia products and traditional Chinese medicines

A vertically integrated global leader in the manufacturing of all natural stevia products and traditional Chinese medicines A vertically integrated global leader in the manufacturing of all natural stevia products and traditional Chinese medicines September 2010 www.sunwininternational.com www.onlysweet.com Legal Statemente

More information

INVESTOR PRESENTATION

INVESTOR PRESENTATION INVESTOR PRESENTATION JUNE 2016 OTCQB:CANN ABOUT General Cannabis Corporation (GCC) is the all-in-one resource for the highest quality service providers available to the regulated Cannabis Industry. We

More information

Sweeteners Overview. Nutritionists in Industry /SENSE meeting 24 April 2012

Sweeteners Overview. Nutritionists in Industry /SENSE meeting 24 April 2012 Sweeteners Overview Nutritionists in Industry /SENSE meeting 24 April 2012 Helen Munday Director Scientific and Regulatory Affairs, Coca-Cola Great Britain and Ireland 1 What needs to be considered? Consumers

More information

Dynavax Corporate Presentation

Dynavax Corporate Presentation Dynavax Corporate Presentation Forward-Looking Statements This presentation contains forward-looking statements, including statements regarding our HEPLISAV-B TM regulatory submissions, product profile,

More information

LEERINK GLOBAL HEALTHCARE CONFERENCE. Marino Garcia EVP, Chief Strategy Officer February 15, 2017

LEERINK GLOBAL HEALTHCARE CONFERENCE. Marino Garcia EVP, Chief Strategy Officer February 15, 2017 LEERINK GLOBAL HEALTHCARE CONFERENCE Marino Garcia EVP, Chief Strategy Officer February 15, 2017 SAFE HARBOR STATEMENT This presentation and any statements made for and during any presentation or meeting

More information

Intercell and Novartis form world leading strategic partnership to drive vaccines innovation

Intercell and Novartis form world leading strategic partnership to drive vaccines innovation Intercell and Novartis form world leading strategic partnership to drive vaccines innovation Alliance creates opportunity for two strong innovators to combine development efforts in attractive areas Intercell

More information

Investor Presentation

Investor Presentation Investor Presentation Spring 2019 OTCQX:MDCL www.medicinemantechnologies.com SAFE HARBOR STATEMENT: This presentation may contain forward looking statements which are based on current expectations, forecasts,

More information

Fiscal 2019 Annual Meeting of Shareholders December 18, Presentation by Lori Woods, Chief Executive Officer

Fiscal 2019 Annual Meeting of Shareholders December 18, Presentation by Lori Woods, Chief Executive Officer Fiscal 2019 Annual Meeting of Shareholders December 18, 2018 Presentation by Lori Woods, Chief Executive Officer Safe Harbor Statement Statements in this presentation about IsoRay's future expectations,

More information

NASDAQ: CYTR FIGHTING CANCER WITH CUTTING EDGE SCIENCE. Corporate Overview. July 2018

NASDAQ: CYTR FIGHTING CANCER WITH CUTTING EDGE SCIENCE. Corporate Overview. July 2018 NASDAQ: CYTR Corporate Overview July 2018 CytRx Safe Harbor Statement THIS PRESENTATION CONTAINS FORWARD-LOOKING STATEMENTS THAT INVOLVE CERTAIN RISKS AND UNCERTAINTIES. ACTUAL RESULTS COULD DIFFER MATERIALLY

More information

Proprietary Pipeline

Proprietary Pipeline Revenue Generating Commercial portfolio with highquality, differentiated products in the Canadian market Proprietary Pipeline Reformulation development pipeline for drugs with a need for improved compliance

More information

COMPANY PRESENTATION. Bernard Fortier, CEO

COMPANY PRESENTATION. Bernard Fortier, CEO COMPANY PRESENTATION Bernard Fortier, CEO Forward Looking Statements Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address

More information

Investor Presentation

Investor Presentation Investor Presentation January 2012 Forward Looking Statements Statements contained herein that are not historical facts are forward-looking statements within the meaning of the Securities Act of 1933,

More information

ARTIFICIAL SWEETENERS: A MARKET WATCH

ARTIFICIAL SWEETENERS: A MARKET WATCH ARTIFICIAL SWEETENERS: A MARKET WATCH BARPETE P. K. 1 *, SINGH S. 2 1, Malhotra College of Pharmacy, Bhopal, M.P-India 2, Dabur Pharma, Delhi-India ABSTRACT Artificial sweeteners are so much sweeter than

More information

Mazen Animal Health. Jennifer Filbey, Ph.D. CEO March 2017

Mazen Animal Health. Jennifer Filbey, Ph.D. CEO March 2017 Mazen Animal Health Jennifer Filbey, Ph.D. CEO March 2017 Revolutionary Way to Prevent Disease and Save the Producer Money 2 The Strategic Opportunity NOVEL VACCINE production platform in maize enables

More information

Welcome to Galenicum! APRIL, 2013

Welcome to Galenicum! APRIL, 2013 Welcome to Galenicum! APRIL, 2013 Our corporate image comes from the sunrise. Night represents disease, daylight means health and the sunrise stands for overcoming GALENICUM CORPORATE PRESENTATION 3 Who

More information

Visionary Private Equity Group is Pleased to Announce its Investment in MEDITE Cancer Diagnostics

Visionary Private Equity Group is Pleased to Announce its Investment in MEDITE Cancer Diagnostics Dear VPEG Limited Partner, We hope this investor update finds you well. We're pleased to share with you an important update below on the following: Visionary Private Equity Group is Pleased to Announce

More information

For personal use only

For personal use only ASX ANNOUNCEMENT 22 NOVEMBER 2017 AGM ADDRESSES FROM THE CHAIRMAN & CEO 22 November 2017 Cann Group Limited (ASX: CAN) is pleased to provide the following addresses to be delivered by its Chairman Allan

More information

For personal use only

For personal use only Australian Securities Exchange Limited Companies Announcements Office SYDNEY 4 April, 2012 New Australian Drug Developer Lists on ASX Key points Growth-focused Australian drug and therapeutic development

More information

Master of Science in Management: Fall 2018 and Spring 2019

Master of Science in Management: Fall 2018 and Spring 2019 Master of Science in Management: Fall 2018 and Spring 2019 2 - Required Professional Development & Career Workshops MGMT 7770 Prof. Development Workshop 1/Career Workshops (Fall) Wed. 9am, 12pm & 3pm MGMT

More information

SPECIALTY MEDICAL CANNABIS COMPANY

SPECIALTY MEDICAL CANNABIS COMPANY SPECIALTY MEDICAL CANNABIS COMPANY TSX Venture: RVV OTCQB: RVVTF Corporate Presentation - August 2018 ReviveThera.com Revive Therapeutics Ltd. Office: 905-605-5535 E-mail: info@revivethera.com Forward

More information

Global Stevia Market: Size, Trends & Forecasts ( ) July 2017

Global Stevia Market: Size, Trends & Forecasts ( ) July 2017 Global Stevia Market: Size, Trends & Forecasts (2017-2021) July 2017 Global Stevia Market Scope of the Report The report entitled Global Stevia Market: Size, Trends & Forecasts (2017-2021), provides analysis

More information

Pierre Legault CEO June 2, 2014

Pierre Legault CEO June 2, 2014 April 2012 Pierre Legault CEO June 2, 2014 Forward Looking Statements This presentation includes statements that are, or may be deemed, forward-looking statements. In some cases, these forward-looking

More information

XXII: CTP Summarizes Scientific Case for Limiting Nicotine in Cigarettes. Company Update October 15, 2018 Industrial & Consumer Technology

XXII: CTP Summarizes Scientific Case for Limiting Nicotine in Cigarettes. Company Update October 15, 2018 Industrial & Consumer Technology Company Update Industrial & Consumer Technology (XXII - $2.81 - Buy) COMPANY NOTE JAMES McILREE, CFA, Senior Research Analyst, +1-646-465-9034 jmcilree@chardan.com Sales and trading 7 a.m. to 7 p.m. ET,

More information

34 th Annual J.P. Morgan Healthcare Conference

34 th Annual J.P. Morgan Healthcare Conference JANUARY 2016 34 th Annual J.P. Morgan Healthcare Conference [ 1 ] Forward Looking Statements SPECIAL NOTE REGARDING FORWARD LOOKING STATEMENTS In addition to historical information, this presentation contains

More information

DIRECT SPINAL THERAPEUTICS INC.

DIRECT SPINAL THERAPEUTICS INC. DIRECT SPINAL THERAPEUTICS INC. Novel Spinal Cord Modulation Platform Overview Presentation May 2014 Direct Spinal Therapeutics Inc. (DSTI) Proprietary Neuromodulation product/platform originated at Univ.

More information

Avenue Therapeutics, Inc. August 2016

Avenue Therapeutics, Inc. August 2016 Avenue Therapeutics, Inc. August 2016 Forward Looking Statements Statements in this presentation that are not descriptions of historical facts are forward looking statements within the meaning of the safe

More information

Medicinal Marijuana Forum Mona School of Business & Management Aug. 30 th, Kamau Chionesu

Medicinal Marijuana Forum Mona School of Business & Management Aug. 30 th, Kamau Chionesu Medicinal Marijuana Forum Mona School of Business & Management Aug. 30 th, 2017 Kamau Chionesu kamau.chionesu02@uwimona.edu.jm Questions 1. What are the likely key requirements for successful participation

More information

Master of Business Administration: Fall 2017/Spring 2018/Fall Semesters (45 Credits)

Master of Business Administration: Fall 2017/Spring 2018/Fall Semesters (45 Credits) Master of Business Administration: Fall 2017/Spring 2018/Fall 2018-3 Semesters (45 Credits) 4 Required non-credit courses: MGMT 6010 Heroes, Leaders & Innovators (Fall) TBA MGMT 7230 Professional Development

More information

Leading Cannabinoid Patient Care in Canada. Corporate Presentation July 2017 TSXV: CMM OTCQB: CAMDF

Leading Cannabinoid Patient Care in Canada. Corporate Presentation July 2017 TSXV: CMM OTCQB: CAMDF Leading Cannabinoid Patient Care in Canada Corporate Presentation July 2017 TSXV: CMM OTCQB: CAMDF Forward Looking Statements Except for historical information, this presentation contains forward-looking

More information

N A S D A Q : E V F M

N A S D A Q : E V F M N A S D A Q : E V F M Jefferies Global Healthcare Conference June 7, 2018 Disclaimer This presentation contains forward looking statements within the meaning of The Private Securities Litigation Reform

More information

36th Annual J.P. Morgan Healthcare Conference. Kevin Conroy, Chairman and CEO January 9, 2018

36th Annual J.P. Morgan Healthcare Conference. Kevin Conroy, Chairman and CEO January 9, 2018 36th Annual J.P. Morgan Healthcare Conference Kevin Conroy, Chairman and CEO January 9, 2018 1 Safe harbor statement This presentation contains forward-looking statements within the meaning of Section

More information

Master of Science in Management: Fall 2017 and Spring 2018

Master of Science in Management: Fall 2017 and Spring 2018 Master of Science in Management: Fall 2017 and Spring 2018 2 - Required Professional Development & Career Workshops MGMT 7770 Prof. Development Workshop 1/Career Workshops (Fall) Wed. 9am, 12pm & 3pm MGMT

More information

Investor presentation. Bioshares Biotech Summit July 2017

Investor presentation. Bioshares Biotech Summit July 2017 Investor presentation Bioshares Biotech Summit 2017 22 July 2017 1 Disclaimer Some of the information in this presentation may refer to Dimerix Limited ( Dimerix or the Company ) based on information available

More information

OWC PHARMACEUTICAL RESEARCH OTCQB:OWCP

OWC PHARMACEUTICAL RESEARCH OTCQB:OWCP OWC PHARMACEUTICAL RESEARCH OTCQB:OWCP Disclaimer This document details business information of OWC Pharmaceuticals Research Corp and/or our wholly-owned Israeli subsidiary, One World Cannabis Ltd. (collectively,

More information

Presentation to 2019 JP Morgan Healthcare Conference

Presentation to 2019 JP Morgan Healthcare Conference For immediate release 10 January 2019 Presentation to 2019 JP Morgan Healthcare Conference Please find attached CSL Limited s presentation at the 2019 JP Morgan Healthcare Conference. For further information,

More information

Avenue Therapeutics, Inc. September 2016

Avenue Therapeutics, Inc. September 2016 Avenue Therapeutics, Inc. September 2016 Forward Looking Statements Statements in this presentation that are not descriptions of historical facts are forward looking statements within the meaning of the

More information

GLG Pharma, LLC. A Specialty Pharmaceutical Company developing the next generation of targeted drugs

GLG Pharma, LLC. A Specialty Pharmaceutical Company developing the next generation of targeted drugs GLG Pharma, LLC A Specialty Pharmaceutical Company developing the next generation of targeted drugs Privately Held Company Summary Experienced Management Team Development stage full spectrum Marketed Products:

More information

RespireRx Pharmaceuticals Inc. Executives Presenting at the International Cannabinoid Derived Pharmaceuticals Summit

RespireRx Pharmaceuticals Inc. Executives Presenting at the International Cannabinoid Derived Pharmaceuticals Summit RespireRx Pharmaceuticals Inc. Executives Presenting at the International Cannabinoid Derived Pharmaceuticals Summit December 11 12, 2018 Workshops, December 10, 2018 The Revere Hotel 200 Stuart St., Boston,

More information

For personal use only. A new company with: a new technology platform for cancer drug development a new management team a new Board

For personal use only. A new company with: a new technology platform for cancer drug development a new management team a new Board A new company with: a new technology platform for cancer drug development a new management team a new Board Disclaimer This presentation is confidential and is not an offer or a recommendation or intended

More information

Annual General Meeting 25 October Cogstate Ltd. All rights reserved.

Annual General Meeting 25 October Cogstate Ltd. All rights reserved. Annual General Meeting 25 October 2017 2017 Cogstate Ltd. All rights reserved. Board of Directors Audit, Risk & Compliance Committee Remuneration & Nomination Committee Martyn Myer Non-Exec Chairman Yes

More information

Avenue Therapeutics, Inc. May 2017

Avenue Therapeutics, Inc. May 2017 Avenue Therapeutics, Inc. May 2017 Forward Looking Statements Statements in this presentation that are not descriptions of historical facts are forward looking statements within the meaning of the safe

More information

Wednesday 26 th November 2008 The ASX Company Announcements office: Chairman s AGM Address

Wednesday 26 th November 2008 The ASX Company Announcements office: Chairman s AGM Address Advanced Molecular Diagnostic Systems The Walter and Eliza Hall Biotechnology Centre, 4 Research Avenue, La Trobe R&D Park, Bundoora, Victoria 3083 T: +61 (0)3 9345 2127 F: +61 (0)3 9345 2242 Wednesday

More information

Marketing Health and Nutrition: Does it Work?

Marketing Health and Nutrition: Does it Work? Marketing Health and Nutrition: Does it Work? Julie G. Adams Almond Board of California 14 June 2011 1 Case Study in less than 15 minutes! Why demand creation is a must, not an option, for almonds Capitalizing

More information

Investor Presentation September Cogstate Ltd. All rights reserved.

Investor Presentation September Cogstate Ltd. All rights reserved. Investor Presentation September 2017 2017 Cogstate Ltd. All rights reserved. We believe that brain health is profoundly important to quality of life and should be easier to measure. That s why we so passionately

More information

Investor Presentation

Investor Presentation ASX:THC B u i l d i n g a M e d i c i n a l C a n n a b i s B u s i n e s s Investor Presentation November 2017 DISCLAIMER The material in this presentation (material) is not and does not constitute an

More information

CAELUM BIOSCIENCES. Corporate Overview May, 2017

CAELUM BIOSCIENCES. Corporate Overview May, 2017 CAELUM BIOSCIENCES Corporate Overview May, 2017 Forward Looking Statements Statements in this presentation that are not descriptions of historical facts are forward looking statements within the meaning

More information

22nd Century Group, Inc. (XXII - $ Buy) Q1 Far Ahead of Expectations

22nd Century Group, Inc. (XXII - $ Buy) Q1 Far Ahead of Expectations Company Update Industrial & Consumer Technology 22nd Century Group, Inc. (XXII - $2.21 - Buy) COMPANY NOTE Estimate Change JAMES McILREE, CFA, Senior Research Analyst, +1-646-465-9034 jmcilree@chardan.com

More information

Aviragen Therapeutics, Inc. and Vaxart Inc. Joint Conference Call UNLOCKING THE FULL POTENTIAL OF ORAL VACCINES

Aviragen Therapeutics, Inc. and Vaxart Inc. Joint Conference Call UNLOCKING THE FULL POTENTIAL OF ORAL VACCINES Aviragen Therapeutics, Inc. and Vaxart Inc. Joint Conference Call UNLOCKING THE FULL POTENTIAL OF ORAL VACCINES October 30, 2017 Safe Harbor This presentation contains forward-looking statements about

More information

Corporate Presentation. October 2017

Corporate Presentation. October 2017 AEPP Breakthrough technology for women s cancers Corporate Presentation October 2017 Oncolix 2017 1 Safe Harbor Certain of the statements and the projections set forth in this presentation constitute forward-looking

More information

AXIM Biotechnologies Reports Year End 2017 Results

AXIM Biotechnologies Reports Year End 2017 Results March 19, 2018 AXIM Biotechnologies Reports Year End 2017 Results NEW YORK, March 19, 2018 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC:AXIM), a world leader in cannabinoid research

More information

Corporate Presentation September 2017

Corporate Presentation September 2017 Enhancing Life Through Nature TSX: CZO Corporate Presentation September 2017 www.ceapro.com 2 Forward Looking Statements This presentation contains forward-looking statements. Various factors could cause

More information

www. isotopeworld.com Advanced Medical Isotope Corporation

www. isotopeworld.com Advanced Medical Isotope Corporation www. isotopeworld.com Advanced Medical Isotope Corporation www. isotopeworld.com James C. Katzaroff Founder, CEO, Chairman December 5, 2016 Safe Harbor Statement This Overview contains forward-looking

More information

Master of Business Administration: Fall 2018/Spring 2019/Fall Semesters (45 Credits)

Master of Business Administration: Fall 2018/Spring 2019/Fall Semesters (45 Credits) Master of Business Administration: Fall 2018/Spring 2019/Fall 2019-3 Semesters (45 Credits) 3 Required non-credit courses: MGMT 7230 Professional Development Workshop I (Fall) - Wednesday 2-3:50pm MGMT

More information

N a s d a q : I N S Y

N a s d a q : I N S Y N a s d a q : I N S Y 0 Safe Harbor Statement This presentation contains both historical information and forward-looking statements. Forward-looking statements are based on management's current expectations

More information

SPECIALTY MEDICAL CANNABIS COMPANY

SPECIALTY MEDICAL CANNABIS COMPANY SPECIALTY MEDICAL CANNABIS COMPANY TSX Venture: RVV OTCQB: RVVTF Corporate Presentation - August 2018 ReviveThera.com Revive Therapeutics Ltd. Office: 905-605-5535 E-mail: info@revivethera.com Forward

More information

DuPont Nutrition & Health Craig Binetti, President

DuPont Nutrition & Health Craig Binetti, President Craig Binetti, President Regulation G The attached charts include company information that does not conform to generally accepted accounting principles (GAAP). Management believes that an analysis of this

More information

OWC PHARMACEUTICALS RESEARCH OTCQB:OWCP

OWC PHARMACEUTICALS RESEARCH OTCQB:OWCP OWC PHARMACEUTICALS RESEARCH OTCQB:OWCP Disclaimer This document details business information of OWC Pharmaceuticals Research Corp and/or our wholly-owned Israeli subsidiary, One World Cannabis Ltd. (collectively,

More information

Annual General Meeting

Annual General Meeting Annual General Meeting November 2017 ASX: MEB OTCQB: MDBIF Medibio Limited 2016 2 DISCLAIMER FORWARD LOOKING STATEMENTS Accordingly, these slides and the information they contain should be read in conjunction

More information

Investor Presentation May 2, 2017

Investor Presentation May 2, 2017 CSE: TBP OTC: GRPOF Investor Presentation May 2, 2017 Forward Looking Statements This presentation contains certain forward-looking statements that may involve a number of risks and uncertainties. Actual

More information

37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE

37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE 37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE January 2019 Safe Harbor Statement This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as

More information

Developing Xanamem for Alzheimer s Dementia

Developing Xanamem for Alzheimer s Dementia Developing Xanamem for Alzheimer s Dementia Dr. Bill Ketelbey CEO, Actinogen Medical Investor Presentation March 2015 Forward Statements This presentation has been prepared by Actinogen Limited. ( Actinogen

More information

Update FDA/Center for Food Safety and Applied Nutrition

Update FDA/Center for Food Safety and Applied Nutrition Update FDA/Center for Food Safety and Applied Nutrition Comments by Susan Mayne, Ph.D. Director Center for Food Safety and Applied Nutrition FDLI Annual Conference May 3, 2018 Food Safety, Nutrition and

More information

Letter to Shareholders

Letter to Shareholders Letter to Shareholders February 2019 Dear Fellow Shareholders: As Co-Founder and Chief Executive Officer of Medicine Man Technologies, Inc. (OTCQX: MDCL), I want to thank you for being a shareholder in

More information

Future Leaders in the Biotech Industry. Lee Bendekgey, SVP, CFO & General Counsel April 7, 2005

Future Leaders in the Biotech Industry. Lee Bendekgey, SVP, CFO & General Counsel April 7, 2005 Future Leaders in the Biotech Industry Lee Bendekgey, SVP, CFO & General Counsel April 7, 2005 Safe Harbor This presentation contains "forward-looking statements" regarding potential use of Nuvelo clinical

More information

Eat Your Peas And Read Your Dietary Guidelines

Eat Your Peas And Read Your Dietary Guidelines Portfolio Media. Inc. 860 Broadway, 6th Floor New York, NY 10003 www.law360.com Phone: +1 646 783 7100 Fax: +1 646 783 7161 customerservice@law360.com Eat Your Peas And Read Your Dietary Guidelines Law360,

More information

BioDiem to present at Hong Kong biotech investment forum

BioDiem to present at Hong Kong biotech investment forum ASX Announcement BIODIEM LTD ABN 20 096 845 993 Suite 3, Level 11, 470 Collins Street, Melbourne, Victoria, 3000 Australia Phone: +613 9613 4100 Web: www.biodiem.com BioDiem to present at Hong Kong biotech

More information

Key figures (consolidated)

Key figures (consolidated) Nestlé Group 2013 Key figures (consolidated) In millions of CHF (except for data per share) 2013 Results Sales 92158 Trading operating profit 14047 as % of sales 15.2% Profit for the year attributable

More information

ST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015

ST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015 ST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015 1 FORWARD LOOKING STATEMENT This presentation contains forward-looking statements within the meaning of the Private Securities Litigation

More information

Imarc

Imarc Imarc www.imarcgroup.com Global Sorbitol (Glucitol) Market Report & Forecast: Market Size, Share, Growth, Production Capacity, Price, Applications, Feedstocks, Manufacturers and Forecast: 2013-2017 March

More information

Chronic illness is a growing market for Novo Nordisk

Chronic illness is a growing market for Novo Nordisk Chronic illness is a growing market for Novo Nordisk Aslam Dalvi - Associate Portfolio Manager Denmark-based global healthcare company Novo Nordisk traces its origins to the first pioneers in insulin production

More information

Positioned for Growth

Positioned for Growth Positioned for Growth Annual Shareholders Meeting July 21, 2016 Paris Panayiotopoulos President and Chief Executive Officer David Sachs Non small cell lung cancer ARIAD clinical trial patient This presentation

More information

Cochlear Limited 2017 Annual General Meeting Chairman s Address

Cochlear Limited 2017 Annual General Meeting Chairman s Address Cochlear Limited 2017 Annual General Meeting Chairman s Address 17 October 2017 Rick Holliday-Smith Chairman Ladies and gentlemen Financial results Cochlear reported a record net profit of $224 million,

More information

Investment in MGC Pharmaceuticals

Investment in MGC Pharmaceuticals Investment in MGC Pharmaceuticals Investor Presentation May 2015 Disclaimer This presentation has been prepared by Erin Resources Limited ( Company ). It does not purport to contain all the information

More information

of note Sensory science addresses sugar reduction challenges

of note Sensory science addresses sugar reduction challenges of note Sensory science addresses sugar reduction challenges Reduction and replacement of sugar is a complex matter for food and beverage manufacturers. Sugar substitutes, sweeteners and sweetness enhancers

More information

RULES OF CONDUCT OF INSIDERS RESPECTING

RULES OF CONDUCT OF INSIDERS RESPECTING T RULES OF CONDUCT OF INSIDERS RESPECTING RADING O F SECURITIES OF TFI International lnc. Amended and restated July 2015 Executive Summary As an insider of TFI International Inc. ( TFI International )

More information

For personal use only

For personal use only Cancer killing viruses Oncolytic Virotherapeutics Bryan Dulhunty Managing Director Bell Potter Life Sciences Conference Building a Global Profile May 2102 bryan.dulhunty@viralytics.com www.viralytics.com

More information

Sumitomo Pharmaceuticals reaches a basic agreement to merge with Dainippon Pharmaceutical

Sumitomo Pharmaceuticals reaches a basic agreement to merge with Dainippon Pharmaceutical For immediate release November 25, 2004 Sumitomo Pharmaceuticals reaches a basic agreement to merge with Dainippon Pharmaceutical Sumitomo Chemical Co., Ltd. announced today that its subsidiary, Sumitomo

More information

New Generation of T-cell Therapeutics

New Generation of T-cell Therapeutics New Generation of T-cell Therapeutics Corporate Overview January 2017 NASDAQ: TPIV 1 Safe Harbor Statement Certain statements contained herein are forward-looking statements within the meaning of the safe

More information